Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non–small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2)
Titel:
Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non–small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2)
Auteur:
Beau-Faller, Michèle Texier, Matthieu Blons, Hélène Richard, Nicolas Escande, Fabienne Melaabi, Samia Lizard, Sarab De Fraipont, Florence Longchampt, Elisabeth Morin, Franck Zalcman, Gérard Pignon, Jean-Pierre Cadranel, Jacques